Safety Reporting

Current section refers to the item 4.11 Safety Reporting of the INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE E6(R2). It provides an overview of requirements for reporting of Serious Adverse Events occurring during a clinical trial.

 

4.11.1 All serious adverse events (SAEs) should be reported immediately to the sponsor except for those SAEs that the protocol or other document (e.g., Investigator's Brochure) identifies as not needing immediate reporting. The immediate reports should be followed promptly by detailed, written reports.

The immediate and follow-up reports should identify subjects by unique code numbers assigned to the trial subjects rather than by the subjects' names, personal identification numbers, and/or addresses.

The investigator should also comply with the applicable regulatory requirement(s) related to the reporting of unexpected serious adverse drug reactions to the regulatory authority(ies) and the IRB/IEC.

4.11.2 Adverse events and/or laboratory abnormalities identified in the protocol as critical to safety evaluations should be reported to the sponsor according to the reporting requirements and within the time periods specified by the sponsor in the protocol.

4.11.3 For reported deaths, the investigator should supply the sponsor and the IRB/IEC with any additional requested information (e.g., autopsy reports and terminal medical reports).

Clinical Research News

Can a Blood Test Safely Screen for Ovarian Cancer in Women at Average Risk?
Dopo l’intervento non si rileva tumore al seno invasivo, ma il DNA tumorale resta rilevabile nel sangue: bisogna intensificare la terapia?
Le persone anziane devono assumere aspirina per tutta la vita dopo un infarto o uno stent?
Si può evitare la lumpectomia in alcuni piccoli tumori della mammella? Uno studio testa una sola seduta di radioterapia ad alta precisione
Un’iniezione al mese può aiutare a mantenere la perdita di peso dopo Wegovy o Zepbound?
Non è un altro GLP-1: petrelintide entra in fase III con 3.900 partecipanti
Si possono trattare le vene varicose senza aghi, cateteri né calore? Un nuovo metodo viene testato per la prima volta nell’uomo

Prossimi studi clinici

Clinical Research Jobs

More jobs

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

Sottoscrivi